Laxmi Organic Industries Limited — Investor Meet, 04-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Laxmi Organic's Q3 saw revenue down ~9%, EBITDA at INR 50 Cr (-33% YoY), and PAT at INR 25 Cr. Specialties revenue declined 30% due to price moderation and an agro product phase-out, while Essentials revenue dipped 6% amid acetic acid price pressure. One-time gains of INR 40.7 Cr from a litigation settlement provided some relief.

Management noted green shoots in the global chemical industry with acetic acid prices rebounding. Dahej Phase 2 is set for Q4 completion, with ramp-up targeted for FY27-28. Fluorination operations at Lote are on track for INR 70-80 Cr top line this fiscal. The company is focused on productivity, cost discipline, and new growth projects. Outlook is cautious but confident, banking on strategic expansions and operational efficiencies.